Sandbox 645: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 51: | Line 51: | ||
2) Indinavir (Crixivan) this protease inhibitor is an oral medication that blocks the protease activity and leads to defect the viruses. Once these viruses are unable to reach the body’s cells, it will decrease in number. | 2) Indinavir (Crixivan) this protease inhibitor is an oral medication that blocks the protease activity and leads to defect the viruses. Once these viruses are unable to reach the body’s cells, it will decrease in number. | ||
[[Image:Indinav1.gif|thumb|center|Ritonavir has a molecular weight of 711.88. It is very soluble in water and in methanol.]] | [[Image:Indinav1.gif|600px|thumb|center|Ritonavir has a molecular weight of 711.88. It is very soluble in water and in methanol.]] | ||
This inhibitor doesn’t have the ability to prevent the HIV transmission among individuals, nor does it cure AIDS or HIV infection. <scene name='User:David_Canner/Sandbox_HIV/Indinavir/2'>Indinavir </scene> ([[Crixivan]])is approved by the FDA in March 1995. <ref>PMID: 11363398</ref> | This inhibitor doesn’t have the ability to prevent the HIV transmission among individuals, nor does it cure AIDS or HIV infection. <scene name='User:David_Canner/Sandbox_HIV/Indinavir/2'>Indinavir </scene> ([[Crixivan]])is approved by the FDA in March 1995. <ref>PMID: 11363398</ref> | ||
